These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 30678358)

  • 21. Effect of quercetin and glucuronide metabolites on the monoamine oxidase-A reaction in mouse brain mitochondria.
    Yoshino S; Hara A; Sakakibara H; Kawabata K; Tokumura A; Ishisaka A; Kawai Y; Terao J
    Nutrition; 2011; 27(7-8):847-52. PubMed ID: 21371861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase.
    Nel MS; Petzer A; Petzer JP; Legoabe LJ
    Bioorg Chem; 2016 Dec; 69():20-28. PubMed ID: 27662218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoamine oxidase inhibitory components from Cayratia japonica.
    Han XH; Hong SS; Hwang JS; Lee MK; Hwang BY; Ro JS
    Arch Pharm Res; 2007 Jan; 30(1):13-7. PubMed ID: 17328236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase.
    Engelbrecht I; Petzer JP; Petzer A
    Bioorg Med Chem Lett; 2015 May; 25(9):1896-900. PubMed ID: 25857942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, biological evaluation and molecular modeling studies of phenyl-/benzhydrylpiperazine derivatives as potential MAO inhibitors.
    Kumar B; Sheetal ; Mantha AK; Kumar V
    Bioorg Chem; 2018 Apr; 77():252-262. PubMed ID: 29421700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.
    Naoi M; Riederer P; Maruyama W
    J Neural Transm (Vienna); 2016 Feb; 123(2):91-106. PubMed ID: 25604428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugs related to monoamine oxidase activity.
    Fišar Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():112-24. PubMed ID: 26944656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and Evaluation of 2-benzylidene-1-tetralone Derivatives for Monoamine Oxidase Inhibitory Activity.
    Amakali KT; Legoabe LJ; Petzer A; Petzer JP
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):136-149. PubMed ID: 29714148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C6- and C7-Substituted 3,4-dihydro-2(1H)-quinolinones as Inhibitors of Monoamine Oxidase.
    Meiring L; Petzer JP; Petzer A
    Drug Res (Stuttg); 2017 Mar; 67(3):170-178. PubMed ID: 27926950
    [No Abstract]   [Full Text] [Related]  

  • 30. Discovery, biological evaluation, and structure-activity and -selectivity relationships of 6'-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N-methylacetamides, a novel class of potent and selective monoamine oxidase inhibitors.
    Pisani L; Barletta M; Soto-Otero R; Nicolotti O; Mendez-Alvarez E; Catto M; Introcaso A; Stefanachi A; Cellamare S; Altomare C; Carotti A
    J Med Chem; 2013 Mar; 56(6):2651-64. PubMed ID: 23437843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the inhibitory effects of quercetin-related flavonoids and tea catechins on the monoamine oxidase-A reaction in mouse brain mitochondria.
    Bandaruk Y; Mukai R; Kawamura T; Nemoto H; Terao J
    J Agric Food Chem; 2012 Oct; 60(41):10270-7. PubMed ID: 23009399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3D-QSAR and in-silico Studies of Natural Products and Related Derivatives as Monoamine Oxidase Inhibitors.
    Dhiman P; Malik N; Khatkar A
    Curr Neuropharmacol; 2018; 16(6):881-900. PubMed ID: 29189167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities.
    Kumar B; Gupta VP; Kumar V
    Curr Drug Targets; 2017; 18(1):87-97. PubMed ID: 26648064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-Tetralone derivatives as inhibitors of monoamine oxidase.
    Legoabe LJ; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2758-63. PubMed ID: 24794105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting monoamine oxidase inhibitory activity through ligand-based models.
    Vilar S; Ferino G; Quezada E; Santana L; Friedman C
    Curr Top Med Chem; 2012; 12(20):2258-74. PubMed ID: 23231398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/anticonvulsant agents.
    Secci D; Bolasco A; Chimenti P; Carradori S
    Curr Med Chem; 2011; 18(33):5114-44. PubMed ID: 22050759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MAO inhibitors and their wider applications: a patent review.
    Carradori S; Secci D; Petzer JP
    Expert Opin Ther Pat; 2018 Mar; 28(3):211-226. PubMed ID: 29324067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selected chromone derivatives as inhibitors of monoamine oxidase.
    Legoabe LJ; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5480-4. PubMed ID: 22850212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors.
    Pisani L; Farina R; Nicolotti O; Gadaleta D; Soto-Otero R; Catto M; Di Braccio M; Mendez-Alvarez E; Carotti A
    Eur J Med Chem; 2015 Jan; 89():98-105. PubMed ID: 25462230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
    Legoabe LJ; Petzer A; Petzer JP
    Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.